What processes were undertaken for the development of the KDIGO 2021 Clinical Practice Guideline?
The processes undertaken for the development of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in CKD include appointing Work Group members and the ERT, finalizing guideline development methodology, defining scope and topics of the guideline, formulating clinical questions identifying the Population, Intervention, Comparator, Outcome, Methods (PICOM), selecting topics for systematic evidence review and linking to existing Cochrane Kidney and Transplant systematic reviews, developing and implementing literature search strategies, selecting studies according to predefined inclusion criteria, data extraction and critical appraisal of the literature, evidence synthesis and meta-analysis, grading the quality of the evidence for each outcome across studies, grading the strength of the recommendation, based on the quality of the evidence, and other considerations, finalizing guideline recommendations and supporting rationale, public review in January 2020, guideline update, and finalizing and publishing the guideline. 